Derek is also saying that we won't be selling Anteobind to any other Europium players.
So if this is the key ingredient in what makes our tests so good, we are basically going to being holding the monopoly on its use which will give us a very strong position is releasing superior tests of high quality going forward. Tests that many players simply won't be able to replicate perhaps.
And the only way a company can use the power of Anteobind I guess is taking over Anteotech ....
Ann: InvestorStream Interview Presentation, page-4
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $20.10K | 957.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2097513 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 1247111 | 2 |
View Market Depth
| Last trade - 11.47am 10/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |